Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaohong Long

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Frontiers in Medicine|July 1, 2025
Promoting the development and approval of new traditional Chinese medicines in China: a pooled analysis of data from 2013 to 2024Xiaohong Long, Jie Zhang, Li Yang
Frontiers in Pharmacology|April 2, 2025
A real-world safety surveillance study of aducanumab through the FDA adverse event reporting systemJingjing Huang, Xiaohong Long, Chunyong Chen
Sensors (Basel, Switzerland)|September 12, 2018
Damage Identification for Underground Structure Based on Frequency Response FunctionShengnan Wang, Xiaohong Long, Hui Luo, et al.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = Chinese Journal of Cellular and Molecular Immunology|July 6, 2018
[Lycorine inhibits the proliferation and promotes apoptosis of SGC-7901 gastric cancer cells by downregulating expression of cyclin D1]Xiao Chen, Xiaohong Long, Yu Liao, et al.
Clinical Pharmacology and Therapeutics|January 10, 2026
Assessing the "Drug Loss" and "Drug Lag" for Rare Diseases in China: A Comparative Analysis with the United States (2001-2024)Yong Wang, Yaoyang Tang, Ruirui Du, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 5, 2022
Corynoline protects ang II-induced hypertensive heart failure by increasing PPARα and Inhibiting NF-κB pathwayMengyang Wang, Wu Luo, Tianxiang Yu, et al.
Acta Pharmaceutica Sinica. B|June 9, 2025
Deubiquitinase USP13 alleviates doxorubicin-induced cardiotoxicity through promoting the autophagy-mediated degradation of STINGLiming Lin, Jibo Han, Diyun Xu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 8, 2023
Inhibition of MD2 by natural product-drived JM-9 attenuates renal inflammation and diabetic nephropathy in miceMinxiu Wang, Qianhui Zhang, Shuaijie Lou, et al.
Nature Communications|July 2, 2025
Cardiomyocyte-derived USP13 protects hearts from hypertrophy via deubiquitinating and stabilizing STAT1 in male miceJibo Han, Liming Lin, Zimin Fang, et al.
Circulation Research|February 14, 2023
Dectin-1 Acts as a Non-Classical Receptor of Ang II to Induce Cardiac RemodelingShiju Ye, He Huang, Xue Han, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Frontiers in Medicine|July 1, 2025
Promoting the development and approval of new traditional Chinese medicines in China: a pooled analysis of data from 2013 to 2024Xiaohong Long, Jie Zhang, Li Yang
Frontiers in Pharmacology|April 2, 2025
A real-world safety surveillance study of aducanumab through the FDA adverse event reporting systemJingjing Huang, Xiaohong Long, Chunyong Chen
Sensors (Basel, Switzerland)|September 12, 2018
Damage Identification for Underground Structure Based on Frequency Response FunctionShengnan Wang, Xiaohong Long, Hui Luo, et al.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = Chinese Journal of Cellular and Molecular Immunology|July 6, 2018
[Lycorine inhibits the proliferation and promotes apoptosis of SGC-7901 gastric cancer cells by downregulating expression of cyclin D1]Xiao Chen, Xiaohong Long, Yu Liao, et al.
Clinical Pharmacology and Therapeutics|January 10, 2026
Assessing the "Drug Loss" and "Drug Lag" for Rare Diseases in China: A Comparative Analysis with the United States (2001-2024)Yong Wang, Yaoyang Tang, Ruirui Du, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 5, 2022
Corynoline protects ang II-induced hypertensive heart failure by increasing PPARα and Inhibiting NF-κB pathwayMengyang Wang, Wu Luo, Tianxiang Yu, et al.
Acta Pharmaceutica Sinica. B|June 9, 2025
Deubiquitinase USP13 alleviates doxorubicin-induced cardiotoxicity through promoting the autophagy-mediated degradation of STINGLiming Lin, Jibo Han, Diyun Xu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 8, 2023
Inhibition of MD2 by natural product-drived JM-9 attenuates renal inflammation and diabetic nephropathy in miceMinxiu Wang, Qianhui Zhang, Shuaijie Lou, et al.
Nature Communications|July 2, 2025
Cardiomyocyte-derived USP13 protects hearts from hypertrophy via deubiquitinating and stabilizing STAT1 in male miceJibo Han, Liming Lin, Zimin Fang, et al.
Circulation Research|February 14, 2023
Dectin-1 Acts as a Non-Classical Receptor of Ang II to Induce Cardiac RemodelingShiju Ye, He Huang, Xue Han, et al.
Pageof 2